By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous central nervous system agents > Flibanserin > Flibanserin Dosage
Miscellaneous central nervous system agents
https://themeditary.com/dosage-information/flibanserin-dosage-10279.html

Flibanserin Dosage

Drug Detail:Flibanserin (Flibanserin [ flib-an-ser-in ])

Drug Class: Miscellaneous central nervous system agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Hypoactive Sexual Desire Disorder

100 mg orally once a day at bedtime

Comments:

  • For patients with no improvement in hypoactive sexual desire disorder (HSDD) after 8 weeks, this drug should be discontinued.
  • This drug is not indicated for the treatment of HSDD in postmenopausal women or in men.
  • This drug is not indicated to enhance sexual performance.

Use: Treatment of premenopausal women with acquired, generalized HSDD characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition; problems within the relationship; or the effects of a medication or other drug substance.

Renal Dose Adjustments

No adjustment recommended

Liver Dose Adjustments

Contraindicated

Dose Adjustments

Concomitant use with Moderate or Strong CYP450 3A4 Inhibitors: Contraindicated

  • Flibanserin should not be started until 2 weeks after the last dose of a moderate or strong CYP450 3A4 inhibitor
  • Strong or moderate CYP450 3A4 inhibitors should not be started for 2 days after the last flibanserin dose
  • Use caution with multiple weak CYP450 3A4 inhibitors

Concomitant Use with Alcohol:
  • To reduce the potential interaction with alcohol, patients consuming 3 or more standard alcoholic drinks should skip their daily (bedtime) dose; patients consuming 1 or 2 standard alcoholic drinks should wait at least 2 hours before dosing
  • A standard alcoholic drink contains 14 g of pure alcohol and is equivalent to one 12-ounce regular beer (5% alcohol), 5-ounces wine (12% alcohol), or 1.5 ounces of distilled spirits/shot (40% alcohol).
  • Once a patient has taken their bedtime dose, alcohol should not be consumed until the following day

Precautions

The US FDA requires a Risk Evaluation and Mitigation Strategy (REMS) for Addyi. It includes a medication guide. For additional information: www.fda.gov/REMS

US BOXED WARNINGS: HYPOTENSION AND SYNCOPE IN CERTAIN SETTINGS:

  • Interaction with Alcohol: Use of this drug close in time with alcohol increases the risk of severe hypotension and syncope. Counsel patients to wait at least 2 hours after consuming 1 or 2 standard alcoholic drinks before taking this drug at bedtime or skip their dose if they have consumed 3 or more standard alcoholic drinks that evening.
  • Contraindicated with Strong or Moderate CYP450 3A4 Inhibitors: Concomitant use of this drug with strong or moderate CYP450 3A4 inhibitors increases the concentration of this drug, which can cause severe hypotension and syncope.
  • Contraindicated in Patients with Hepatic Impairment: The concentration of this drug is increased when used in patients with hepatic impairment, which can result in severe hypotension and syncope.

CONTRAINDICATIONS:
  • Concomitant use with moderate or strong CYP450 3A4 inhibitors
  • Hepatic impairment
  • Known hypersensitivity to this drug or any of its components; anaphylaxis consistent with angioedema, pruritus, and urticaria have been reported

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available.

Other Comments

Administration Advice:

  • Take orally once a day at bedtime
  • Missed dose: If a dose is missed, skip the missed dose and resume dosing the next day at bedtime

General:
  • This drug should be only be taken at bedtime because administration during waking hours increases the risks of hypotension, syncope, accidental injury, and CNS depression (e.g., somnolence and sedation).
  • If no improvement in HSDD is achieved in 8 weeks, this drug should be discontinued.

Monitoring:
  • Monitor for hypotension
  • Monitor for somnolence, sedation, and fatigue

Patient advice:
  • Patients should be instructed to read the US FDA-approved patient labeling (Medication Guide).
  • Patients should understand that this drug may cause hypotension and syncope particularly when taken close in time with alcohol, grapefruit juice, or a number of different medications or herbal supplements; patients should discuss all medication and herbal use with their healthcare professional.
  • Patients should understand that alcohol use should be limited, they should understand the limitations to avoid the risk of hypotension and syncope.
  • Patients should be instructed to lie down if they experience lightheadedness; they should seek medical help promptly if symptoms persist.
  • Patients should be instructed not to drive or engage in hazardous tasks until at least 6 hours after their last dose, and until they understand how this drug affects them.

Frequently asked questions

  • Is Addyi just a pink Viagra?
  • Vyleesi vs Addyi: What is the difference?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by